Professor and Head, Pathology and Laboratory Medicine
Pathology
Dr. Stanley R. Hamilton, MD
|
|
Give Review
Stanley Hamilton works in the field of Pathology. He went to Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He over the years received 5 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer", "Whos Who in Medicine and Healthcare" and "Super Doctor". Stanley Hamilton has written publications. He has 95 publications published with PubMed. The lastest paper is: 'The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.' Dr. Stanley R. Hamilton accepts Medicare.
Publications
- The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
- Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European ...
- Pragmatic issues in biomarker evaluation for targeted therapies in cancer.
- Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction.
- Select Biomarkers for Tumors of the Gastrointestinal Tract: Present and Future.
- Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum.
- MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.
- Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer.
- Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome.
- Colorectal adenoma stem-like cell populations: Associations with adenoma characteristics and metachronous colorectal neoplasia.
- The Cancer Genome Atlas Pan-Cancer analysis project.
- CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
- Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Colon and Rectum.
- MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes.
- Cellular location and expression of Na(+) , K(+) -ATPase α subunits affect the anti-proliferative activity of oleandrin.
- Molecular pathology.
- Path Toward Prognostication and Prediction: An Evolving Matrix.
- Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-stable Colorectal Cancer.
- 2010 staging system for colon and rectal carcinoma.
- NGAL Expression is Elevated in both Colorectal Adenoma-Carcinoma Sequence and Cancer Progression and Enhances Tumorigenesis in Xenograft Mouse Models.
- DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis.
- Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.
- Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
- Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
- Microsatellite instability in the peripheral blood leukocytes of HNPCC patients.
- Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps.
- Concordant DNA methylation in synchronous colorectal carcinomas.
- NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells.
- American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict respons...
- Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.
- Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
- Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
- Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases.
- The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression.
- Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention.
- Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
- Targeted therapy of cancer: new roles for pathologists in colorectal cancer.
- Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors.
- Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.
- Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy.
- Activation of polyamine catabolism by N1, N11-diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cells.
- Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk.
- SOX9 is required for the differentiation of paneth cells in the intestinal epithelium.
- Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.
- Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
- Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.
- Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway.
- Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
- The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.
- Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients.
- Inactivation of IkappaB contributes to transcriptional activation of spermidine/spermine N(1)-acetyltransferase.
- Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
- Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
- The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiat...
- Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt.
- The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.
- Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis.
- Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries.
- Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon car...
- MGMT promoter methylation and field defect in sporadic colorectal cancer.
- Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors.
- Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.
- Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice.
- Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human co...
- Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
- Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation.
- BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
- Oral contraceptives and polyp regression in familial adenomatous polyposis.
- Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
- Contribution of bone marrow-derived endothelial cells to human tumor vasculature.
- Combination of 5-fluorouracil and N1,N11-diethylnorspermine markedly activates spermidine/spermine N1-acetyltransferase expression, depletes polyamines, and synergisti...
- Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
- Automated quantification of lymph node size and number in surgical specimens of stage II colorectal cancer.
- Overexpression of caspase-3 in hepatocellular carcinomas.
- Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability.
- Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
- Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.
- Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
- Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas.
- Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value?
- Apoptotic response to 5-fluorouracil treatment is mediated by reduced polyamines, non-autocrine Fas ligand and induced tumor necrosis factor receptor 2.
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
- Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas.
- Frequent CpG island methylation in serrated adenomas of the colorectum.
- P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53.
- Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene.
- Identification of combination gene sets for glioma classification.
- Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.
- Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
- CpG island methylation in aberrant crypt foci of the colorectum.
- Primary chemoprevention of familial adenomatous polyposis with sulindac.
- Evaluation of non-formalin tissue fixation for molecular profiling studies.
- Concordant CpG island methylation in hyperplastic polyposis.
- Detection of APC mutations in fecal DNA from patients with colorectal tumors.
Schools
Indiana University School of Medicine
Johns Hopkins Hospital
St Marks LondonJohns Hopkins
Doctors Specialties
- Pathology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Whos Who in Medicine and Healthcare
- Super Doctor
Education
-
Johns Hopkins University -
Indiana University School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730275637 |
| Last Name Of The Provider | HAMILTON |
| First Name Of The Provider | STANLEY |
| View All |
Similar Doctors
|
|
Dr. Joshua Baalwa, MD |
|
|
Dr. John L. Stavinoha Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Z. Gilcrease, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evelyn T. Sie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cesar A. Moran, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Reka Szigeti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Youli Zu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Khoury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George R. Elias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nishant Tiwari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Anupma Nayak, MB |
|
|
Dr. Mitzi T. Jimenez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alex John, MD |